TherapeuticsMD Inc.
TXMD | NASDAQ
$2.11
+$0.01 (+0.48%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.02M | 1.76M | 1.3M | 69.96M | 2.57M | 64.87M |
Cost of Revenue | 1.19M | n/a | n/a | 1.4M | 1.4M | 15.98M |
Gross Profit | 1.83M | 1.76M | 1.3M | 68.57M | 1.17M | 48.9M |
Operating Income | -4.21M | -4.76M | -8.52M | 1.19M | -79.58M | -155.54M |
Interest Income | 150K | 144.9K | 300K | n/a | n/a | n/a |
Pretax Income | -653K | -2.34M | -7.74M | 1.07M | -79.31M | -183.52M |
Net Income | -569K | -2.18M | -10.28M | 112M | -172.42M | -183.52M |
Selling & General & Admin | 6.85M | 6.1M | 8.9M | 56.71M | 72.75M | 194.01M |
Research & Development | n/a | n/a | n/a | n/a | n/a | 10.43M |
Other Expenses | -809K | 6.52M | 9.83M | 10.67M | 8M | n/a |
Operating Expenses | 6.04M | 6.52M | 9.83M | 67.38M | 80.75M | 204.44M |
Interest Expense | 8K | 9.5K | 200K | n/a | 32.92M | 28.58M |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.19M | n/a | 117.05M |
Cost & Expenses | 7.24M | 6.52M | 9.83M | 68.77M | 82.15M | 220.41M |
Income Tax Expense | n/a | -31K | -43K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 11.57M | 11.53M | 10.44M | 9.03M | 7.96M | 5.51M |
Shares Outstanding (Diluted) | 11.57M | 11.53M | 10.44M | 9.03M | 7.96M | 5.51M |
EPS (Basic) | -0.05 | -0.19 | -0.55 | 12.41 | -25.83 | -38.58 |
EPS (Diluted) | -0.05 | -0.19 | -0.74 | 12.41 | -25.83 | -38.58 |
EBITDA | -3.02M | -2.98M | -8.08M | 11.86M | -70.84M | -153.41M |
EBIT | -4.21M | -3.49M | -8.52M | 10.66M | -71.58M | -157.48M |
Depreciation & Amortization | 1.19M | 509K | 438.5K | 1.2M | 736K | 4.07M |
Add to Watchlist
Select watchlists to add or remove TXMD